Powell Says He'll Stay on Fed Board After Chair Term Ends
Powell will continue to serve on the Federal Reserve Board after his chair term ends next month, steering a measured ...
When To Revise Zero Based Budget Categories
Knowing when to revisit budget categories helps you rebalance spending before it wrecks your plan.
17,280 articles
Aave Warns $71m Exploit Recovery Seizure in Court Fight
Aave asks a New York court to lift a restraining order on ETH set aside for victims of a DeFi breach, arguing the ass...
Sneaky International That’s Quietly Outperforming the S&P
A little-known international ETF is quietly outperforming the S&P 500 this year, riding a multi-factor strategy and l...
Flotek (FTK) 2025 Earnings: Key Takeaways for Investors
As Flotek prepares for its Q3 2025 earnings, investors will parse management tone, margins, and guidance. This articl...
Better Store Value: Bitcoin vs Gold-Backed Stablecoins
Is Bitcoin really the better store value: bitcoin option, or do gold-backed stablecoins offer a compelling alternativ...
Barclays Hikes Atlassian Price Target to $112 on ARR
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
Radian (RDN) 2026 Earnings: Q1 Highlights and Outlook
Radian Group's Q1 2026 earnings narrative reveals how the mortgage insurance business is performing, how risk is mana...
Zymeworks (Zyme) 2026 Earnings: An Investor Guidebook
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
Oklo Stock Surged April: Key Catalysts Behind the Rally
In April, Oklo delivered a sharp rebound that captured investor attention. This in-depth look explains the catalysts,...
DXC: Key Takeaways From (dxc) 2026 Earnings Call Today
In the (dxc) 2026 earnings call, executives outlined the road ahead for DXC Technology's growth, margins, and free ca...
Lumentum’s Fiery Rally Pushes Stock Into Nasdaq 100
Lumentum’s fiery stock rally this year has propelled the optics company into the top tier of the market, signaling a ...
Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status